ロード中...
Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potential curative treatment for hematologic malignancies and non-malignant diseases. Because of the lower toxicity of reduced intensity conditioning, the number of transplants is in constant increase. However, allo-HSCT is still li...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4836046/ https://ncbi.nlm.nih.gov/pubmed/27148267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2016.00148 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|